The proceeds from the offering will be used for research and development, sales, administrative expenses, and working capital. Treatment.com AI Inc. is focused on improving healthcare through its AI-driven Global Library of Medicine, which supports healthcare professionals by reducing administrative burdens and enhancing patient care. The company emphasizes that the securities will not be registered under the U.S. Securities Act and are not for sale in the United States. The announcement includes cautionary statements about forward-looking information and the potential risks involved.
Key takeaways:
- Treatment.com AI Inc. has announced a brokered private placement of 6,000,000 units at C$0.50 per unit for gross proceeds of C$3,000,000.
- Each unit consists of one common share and one-half of one common share purchase warrant, with warrants exercisable at C$0.75 per share for 24 months.
- The offering is expected to close on or before March 12, 2025, and is subject to necessary approvals, including from the Canadian Securities Exchange.
- Proceeds from the offering will be used for research and development, sales, general and administrative expenses, and working capital.